News & Updates

Show Multimedia Only

Patient-reported tool helps assess symptoms, vision perception after IOL implantation

05 Jul 2023

Use of the 37-item Assessment of IntraOcular Lens Implant Symptoms (AIOLIS) instrument appears effective in evaluating symptoms and general perceptions of vision associated with cataract surgery and intraocular lens (IOL) implants, reports a study.

05 Jul 2023

$Ocular pain persists for some patients after refractive surgery$

Ocular pain persists for some patients after refractive surgery

04 Jul 2023

Nearly one in 10 patients report persistent ocular pain after refractive surgery, according to a study, noting several pre- and perioperative factors that can predict pain following the procedure.

04 Jul 2023

Newly diagnosed glaucoma ups risk of dementia

03 Jul 2023

The risk of developing dementia, particularly Alzheimer’s disease (AD), is much higher among individuals with newly diagnosed glaucoma, suggests a study. Additionally, this association is much greater among older individuals.

03 Jul 2023

The unseen comorbidity of diabetes

23 Jun 2023 by

Diabetes is the most prevalent cause of blindness in working-age individuals. However, 64 percent of Malaysians are not aware that diabetes can lead to eye problems. On the other hand, heart disease, kidney disease, and amputations are some of the health issues that come to mind when diabetes is mentioned.

23 Jun 2023

Low-dose atropine helps control childhood myopia progression

18 Jun 2023

The novel, preservative-free, low-dose atropine formulation NVK002 appears to be beneficial in the treatment of myopia progression in children when compared with placebo, according to the results of a phase III study.

18 Jun 2023

OPT-302 2.0 mg plus ranibizumab leads to superior vision gains in nAMD

05 Jun 2023 by

Treatment with 2.0-mg OPT-302, a biologic inhibitor of vascular endothelial growth factor (VEGF)-C and D, in combination with ranibizumab, an anti‒VEGF-A inhibitor, results in greater vision gains when compared with the current standard of care for neovascular age-related macular degeneration (nAMD), reports a study. In addition, the combined therapy has an acceptable safety profile.

05 Jun 2023

Dietary modification ups glaucoma risk in women

04 Jun 2023

Dietary modification (DM) among individuals in the lowest quartile for percentage calories from total fat at baseline is associated with a higher risk of incident primary open-angle glaucoma (POAG) among women, irrespective of age or race, suggests a recent study.

04 Jun 2023

Original New Drug Application Approvals by US FDA (16-31 May 2023)

01 Jun 2023

New drug applications approved by US FDA as of 16-31 May 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

01 Jun 2023

Serum ADMA levels linked to circadian BP variability in glaucoma

27 May 2023

Serum levels of asymmetric dimethylarginine (ADMA) seem to play a major role in the disturbance of circadian blood pressure (BP) variability in patients with glaucoma, suggests a recent study.

27 May 2023

AI raises the bar for diagnosing severe TED

23 May 2023 by

Artificial intelligence (AI) can help diagnose thyroid eye disease (TED) and assess for severity by analysing CT scans, reports an expert at ARVO 2023.

23 May 2023